Episode 4 – Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &Â Scott Power, Investment Committee at Horizon 3 Biotech Â
Episode 3 – Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Chris Behrenbruch from Telix Pharmaceuticals and David Blake.
Episode 2 – Accessing US markets – Nasdaq and FDA approval
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan Baldwin and Phamaxis CEO Gary Phillips.
Episode – Investing in Australian Biotech Webinar
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital Markets Executive Dr Graeme Wald and Investment Analyst Scott Power who will be sharing topical investment strategies. Date: 11:00am to 11:30am Tuesday 13 October 2020
Introduction to Horizon3
Guide to Life Sciences Investing
This Guide to Life Sciences Investing, with foreword from Horizon 3’s Board member Glenn Cross, will provide potential investors in life sciences companies with consolidated, factual, relevant and independent information about the sector. It builds on general investment guidance by featuring key considerations for the life sciences sector. View the PDF
